Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune diseases, today announces that the United States Food and ...

The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms ...

AUSTINTOWN, Ohio (WKBN) – A fundraiser this weekend aims to help a local teenager pursue her cheerleading dreams while ...

Storm Therapeutics has closed a $56 million series C financing as the British biotech kicks off a phase 2 sarcoma trial of ...

Because not all patients with sarcoma can be treated at centers of expertise, it is necessary to find creative ways for them to benefit from these centers when they have no access. Benefits can be ...

The Pfizer-backed Series C round will see Storm work out an accelerated approval pathway for STC-15 in sarcoma.

NCIS leads multi-institutional effort to develop expert multidisciplinary guidance to improve sarcoma diagnosis, referrals and outcomes SINGAPORE, April 11, 2026 /PRNewswire/ -- Singapore is ...

Kimberley Nix was a 28-year-old medical resident when she was diagnosed with metastatic sarcoma. Today, she continues her studies while sharing her journey on social media Stephanie Sengwe is a pop ...

“Sarcoma is a cancer that develops in the bones and soft tissues, including muscles, fat, nerves, and blood vessels. Sarcoma's major symptoms frequently involve a visible bulge or swelling that may be ...

Symptoms of Ewing sarcoma include a visible lump that develops at the tumor site. Other symptoms include a low yet consistent fever, unexplained weight loss, and anemia. This article looks at the ...

FDA orphan drug designation provides incentives including regulatory support, tax credits, fee exemptions, and seven years of ...